glp-1 supply shortage news november 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Societies take stand against off-brand
Description
As the semaglutide patent expiries begin in 2026 across key global markets, Indian pharma companies are racing to capture the opportunity amid rising competition, falling prices & regulatory uncertainty Ekta Bhatra breaks down who stands to gain, the risks ahead, & how GLP-1 drugs could drive the next phase of pharma growth
We cover common side effects such as nausea, vomiting, diarrhea, and constipation, affecting 40-70% of users
Until today, the answer was a mystery
100% online telehealth for weight loss, longevity, and wellness
Predict your weekly weight loss journey with GLP-1 medications including Ozempic, Wegovy, Mounjaro & Zepbound.
Kennedy Jr.'s Make America Healthy Again movement.
